Personalized Therapy of Tyrosine Kinase Inhibitors

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.44.225
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2017English

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2019English

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

Transport of Six Tyrosine Kinase Inhibitors: Active or Passive?

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2016English

Invasive Aspergillosis Complicating Treatment With Tyrosine Kinase Inhibitors

BMJ Case Reports
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy